Tradestie Institutional Equity Comparison Engine

HR vs NHP โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

HR Overall Edge

HR Captures Institutional Edge (2โ€“2 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Healthcare Realty Trust Incorporated (HR) driven by superior Valuation, Growth & Margin while NHP counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, HR trades at 10.8x Forward P/E with 13.2% operating margin (-3.6% YoY revenue) versus NHP at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, HR sits in CONSOLIDATION (9th %ile IV; Dealer Gamma Walls on Pro) against NHP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner HR
HR 10.8x vs NHP N/M Fwd P/E
Growth & Margin Winner HR
Op Margin 13.2% vs N/A ยท YoY -3.6% vs N/A
Momentum & Technical Winner NHP
1Y +8.3% vs +23.5% ยท 52W Pos 53% vs 58%
Options & Structure Winner NHP
CONSOLIDATION (9th %ile IV) vs UNCLASSIFIED (N/A IV)
HR NYSE
Healthcare Realty Trust Incorporated
Real Estate Investment Trusts
$19.36
+0.0% 1D
Market Cap $6.7B
1M Return +7.98%
1Y Return +8.28%
Forward P/E 10.8x
Unified AI Score
48.3 / 100 HOLD
Tech 33.0 Fund 44.0 Flow 48.0 Mom 56.0
NHP US Equity
NHP
Institutional Equity
$14.82
+2.14% 1D
Market Cap N/A
1M Return -6.2%
1Y Return +23.5%
Forward P/E N/M
Unified AI Score
54.6 / 100 HOLD
Tech 64.0 Fund 51.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: HR +8.28% NHP +23.5% Spread: +17.77 pp (NHP Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
HR TTM Op. Margin: 13.2% NHP TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HR vs NHP. Trailing 12-month operating profitability (HR 13.2% vs NHP N/A) and valuation multiples (HR 10.8x vs NHP N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: HR (8) vs NHP (2)
Institutional Metric HR NHP Criterion Row Winner
Market Capitalization Scale $6.7B N/A Larger Scale HR
Trailing P/E Ratio Valuation 10.8x N/M Lower Multiple HR
Forward P/E Ratio Valuation 10.8x N/M Lower Multiple HR
Revenue Growth (YoY) Growth -3.6% N/A Higher Growth HR
Operating Margin (TTM) Profitability 13.2% N/A Higher Margin HR
Net Profit Margin Profitability -4.0% N/A Higher Margin HR
Return on Equity (ROE) Capital Efficiency -1.0% N/A Higher ROE HR
52-Week Range Position Momentum 53% ($16โ€“$22) 58% ($11โ€“$17) Stronger Trend NHP
Beta / 30D Volatility Risk Regime 0.08ฮฒ ยท 21% Vol 0.20ฮฒ ยท 34% Vol Lower Realized Risk HR
Unified Institutional Score Composite Signal 48.3 / 100 (HOLD) 54.6 / 100 (HOLD) Higher Composite NHP

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full HR vs NHP Buy Guide
HR CONSOLIDATION
112d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 9th %ile
IV Regime Compressed (<25th %ile)
Live HR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NHP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NHP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither HR nor NHP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.